Alexis Peyroles
Chief Executive Officer en Ose Immunotherapeutics, Inc. .
Fortuna: 5 M $ al 31/03/2024
Cargos activos de Alexis Peyroles
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Aperana Consulting SAS | Chairman | - | - |
| Ose Immunotherapeutics, Inc. | Chief Executive Officer | - | - |
Historial de carrera de Alexis Peyroles
Antiguos cargos conocidos de Alexis Peyroles.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director/Board Member | 01/05/2016 | 16/01/2022 |
| Chief Executive Officer | 12/04/2018 | 16/01/2022 | |
| Chief Operating Officer | 01/05/2016 | 12/04/2018 | |
| Guerbet Imagem do Brasil Ltda. | Chief Executive Officer | 01/01/2009 | - |
| Sanofi-Aventis Japan | Comptroller/Controller/Auditor | 01/01/1996 | - |
| GUERBET | Comptroller/Controller/Auditor | 01/01/2005 | - |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 01/01/1996 | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Director of Finance/CFO | 01/09/2013 | - |
Formación de Alexis Peyroles.
| École des Hautes Études Commerciales du Nord | Undergraduate Degree |
| Imperial College Business School | Masters Business Admin |
Estadísticas
Internacional
| Francia | 7 |
| Japón | 2 |
| Reino Unido | 2 |
Operativa
| Chief Executive Officer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GUERBET | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Empresas privadas | 6 |
|---|---|
| Sanofi-Aventis Japan | |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Aperana Consulting SAS | |
| Ose Immunotherapeutics, Inc. | |
| Guerbet Imagem do Brasil Ltda. |
- Bolsa de valores
- Insiders
- Alexis Peyroles
- Experiencia
